We possess deep scientific expertise in the chemical and biological mechanisms of blood-based disorders. By leveraging our proprietary knowledge of protein structure and function, comprehensive biological assays and advanced drug discovery, we are able to pursue novel approaches for treating blood-based disorders.

Our expertise includes the following specific capabilities:

  • Conformational modulation (changing the shape) of specific blood-based proteins
  • The binding of molecules to protein targets to activate or inhibit these targets
  • Computational methods in protein structure, dynamics and ligand docking
  • Broad access to diverse libraries of compounds
  • Comprehensive biological assays ranging from purified protein to whole blood and genetically based animal models

  With these expert drug discovery capabilities and a focus on accelerated clinical development strategies, we are able to design and develop novel therapies with the potential for early proof-of-concept and a higher probability of technical success.